MicroRNA miR-874-3p inhibits osteoporosis by targeting leptin (LEP)

Ling Mei1, Min Li2, Tao Zhang3

  • 1Department of Orthopedic, Wuhan Hospital of Traditional Chinese Medicine, Wuhan, Hubei, China.

Bioengineered
|November 25, 2021
PubMed

Insights

MicroRNAs (miRNAs) like miR-874-3p are crucial for bone health. This study found miR-874-3p inhibits osteoporosis by promoting osteogenic differentiation and downregulating leptin (LEP).

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) play a regulatory role in osteogenic differentiation, a process critical for bone metabolism.
  • Osteoporosis (OP) is a condition characterized by reduced bone mass and increased fracture risk, often linked to impaired osteogenesis.
  • Understanding the specific roles of miRNAs in OP pathogenesis is essential for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of miR-874-3p in osteoporosis (OP).
  • To determine the relationship between miR-874-3p, leptin (LEP), and osteogenic differentiation in human bone marrow mesenchymal stem cells (hBMSCs).

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to measure miR-874-3p and LEP expression in patient samples and cell cultures.
  • In vitro experiments involving upregulation of miR-874-3p in hBMSCs to assess effects on cell proliferation and osteogenic markers (ALP, RUNX2, OCN, OSX).
  • Bioinformatics analysis, luciferase reporter assays, and RNA pull-down assays to elucidate the molecular mechanism between miR-874-3p and LEP.

Main Results:

  • miR-874-3p expression was significantly lower in patients with OP, while LEP levels were higher compared to controls.
  • miR-874-3p expression increased during osteogenic differentiation of hBMSCs, whereas LEP expression decreased.
  • Upregulation of miR-874-3p promoted hBMSC proliferation, osteogenic marker expression, and calcium deposition, and LEP was identified as a direct target of miR-874-3p.
  • Overexpression of LEP counteracted the osteogenic effects of miR-874-3p.

Conclusions:

  • miR-874-3p acts as a positive regulator of osteogenic differentiation in hBMSCs.
  • The mechanism involves the downregulation of LEP by miR-874-3p.
  • miR-874-3p may serve as a potential therapeutic target for inhibiting osteoporosis.